- Friday, September 22, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
Welcome
8:15 AM – 9:00 AM ET
Session 9: The Primacy of Front-Line Checkpoint Inhibitors in NSCLC
8:15 AM – 9:00 AM ET
Session 9: The Primacy of Front-Line Checkpoint Inhibitors in NSCLCPresenter: – Princess Margaret Cancer Centre
Natasha Leighl, MD, FRCPC, FASCO – Princess Margaret Cancer Centre ### 1880423###Presenter###Lung Site Lead, Medical Oncology###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
###
9:00 AM – 9:07 AM ET
Session 10: Debate: How to Handle PD-L1 <1% - Chemo + IO
9:00 AM – 9:07 AM ET
Session 10: Debate: How to Handle PD-L1 <1% - Chemo + IODebate Speaker: – Cedars Sinai Medical Center
Karen Reckamp, MD – Cedars Sinai Medical Center ### 799344###Debate Speaker###Professor###Cedars Sinai Medical Center###Debate Speaker: – Cedars Sinai Medical Center
###
9:07 AM – 9:14 AM ET
Session 10: Debate: How to Handle PD-L1 <1% - IO Combos
9:07 AM – 9:14 AM ET
Session 10: Debate: How to Handle PD-L1 <1% - IO CombosDebate Speaker: – Fox Chase Cancer Center
Hossein Borghaei, DO, MS – Fox Chase Cancer Center ### 2014938###Debate Speaker###Professor and Chief, Thoracic Oncology###Fox Chase Cancer Center###Debate Speaker: – Fox Chase Cancer Center
###
9:14 AM – 9:21 AM ET
Session 10: Debate: How to Handle PD-L1 1-49% - Chemo + IO
9:14 AM – 9:21 AM ET
Session 10: Debate: How to Handle PD-L1 1-49% - Chemo + IODebate Speaker: – Cedars Sinai Medical Center
Karen Reckamp, MD – Cedars Sinai Medical Center ### 799344###Debate Speaker###Professor###Cedars Sinai Medical Center###Debate Speaker: – Cedars Sinai Medical Center
###
9:21 AM – 9:28 AM ET
Session 10: Debate: How to Handle PD-L1 1-49% - IO Only
9:21 AM – 9:28 AM ET
Session 10: Debate: How to Handle PD-L1 1-49% - IO OnlyDebate Speaker: – Fox Chase Cancer Center
Hossein Borghaei, DO, MS – Fox Chase Cancer Center ### 2014938###Debate Speaker###Professor and Chief, Thoracic Oncology###Fox Chase Cancer Center###Debate Speaker: – Fox Chase Cancer Center
###
9:28 AM – 9:45 AM ET
Session 10: Debates: How to Handle PD-L1
9:28 AM – 9:45 AM ET
Q&A PanelPanelist: – Fox Chase Cancer Center
Panelist: – Cedars Sinai Medical Center
Hossein Borghaei, DO, MS – Fox Chase Cancer Center ### 2014938###Panelist###Professor and Chief, Thoracic Oncology###Fox Chase Cancer Center###Panelist: – Fox Chase Cancer Center
### @@@ Karen Reckamp, MD – Cedars Sinai Medical Center ### 799344###Panelist###Professor###Cedars Sinai Medical Center###Panelist: – Cedars Sinai Medical Center
### 9:45 AM – 9:50 AM ET
Exhibit Hall
9:45 AM – 9:50 AM ET
Break
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater - Sponsored by Catalyst
10:50 AM – 11:00 AM ET
Exhibit Hall
10:50 AM – 11:00 AM ET
Exhibit Hall
11:00 AM – 11:45 AM ET
Session 11: Fusions as a Target in Lung Cancer: RET, NTRK, NRG1, ROS1
11:00 AM – 11:45 AM ET
Session 11: Fusions as a Target in Lung Cancer: RET, NTRK, NRG1, ROS1Presenter: – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Deborah Doroshow, MD, PhD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai ### 1941811###Presenter###Assistant Professor###Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai###Presenter: – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
###
11:45 AM – 12:30 PM ET
Session 12: Updates from Recent Meetings
11:45 AM – 12:30 PM ET
Session 12: Updates from Recent MeetingsPresenter: – Rush University
Helen J. Ross, MD (she/her/hers) – Rush University ### 758420###Presenter###Thoracic Medical Oncologist, Director of Research and Clinical Trials###Rush University###Presenter: – Rush University
### she/her/hers
12:30 PM – 1:35 PM ET
Lunch Break
12:30 PM – 1:35 PM ET
Lunch Break
1:35 PM – 1:42 PM ET
Debate: How to Handle PD-L1 >50% - Chemo + IO
1:35 PM – 1:42 PM ET
Session 13: Debate: How to Handle PD-L1 >50% - Chemo + IOPresenter: – Johns Hopkins University
Patrick Forde, MD – Johns Hopkins University ### 1765848###Presenter###Co-Director, Division of Upper Aerodigestive Malignancies###Johns Hopkins University###Presenter: – Johns Hopkins University
###
1:42 PM – 1:49 PM ET
Debate: How to Handle PD-L1 >50% - IO Only
1:42 PM – 1:49 PM ET
Session 13: Debate: How to Handle PD-L1 >50% - IO OnlyPresenter: – Memorial Sloan Kettering Cancer Center
Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center ### 758405###Presenter###Associate Attending Physician###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
1:49 PM – 1:56 PM ET
Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
1:49 PM – 1:56 PM ET
Session 13: Debate: Neoadjuvant vs Adjuvant Therapy - NeoadjuvantPresenter: – Memorial Sloan Kettering Cancer Center
Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center ### 758405###Presenter###Associate Attending Physician###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
1:56 PM – 2:03 PM ET
Debate: Neoadjuvant vs Adjuvant Therapy - Adjuvant
1:56 PM – 2:03 PM ET
Session 13: Debate: Neoadjuvant vs Adjuvant Therapy - AdjuvantPresenter: – Johns Hopkins University
Patrick Forde, MD – Johns Hopkins University ### 1765848###Presenter###Co-Director, Division of Upper Aerodigestive Malignancies###Johns Hopkins University###Presenter: – Johns Hopkins University
###
2:03 PM – 2:20 PM ET
Session 13: Debates: How to Handle PD-L1 and Neoadjuvant vs Adjuvant
2:03 PM – 2:20 PM ET
Q&A PanelPanelist: – Johns Hopkins University
Panelist: – Memorial Sloan Kettering Cancer Center
Patrick Forde, MD – Johns Hopkins University ### 1765848###Panelist###Co-Director, Division of Upper Aerodigestive Malignancies###Johns Hopkins University###Panelist: – Johns Hopkins University
### @@@ Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center ### 758405###Panelist###Associate Attending Physician###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### 2:20 PM – 3:05 PM ET
Session 14: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?
2:20 PM – 3:05 PM ET
Session 14: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?Presenter: – Princess Margaret Cancer Centre
Natasha Leighl, MD, FRCPC, FASCO – Princess Margaret Cancer Centre ### 1880423###Presenter###Lung Site Lead, Medical Oncology###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
###
3:05 PM – 3:35 PM ET
Exhibit Hall
3:05 PM – 3:35 PM ET
Exhibit Hall
3:35 PM – 4:20 PM ET
Session 15: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLC
3:35 PM – 4:20 PM ET
Session 15: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLCPresenter: – NYU Langone Health Perlmutter Cancer Center
Joshua K. Sabari, MD – NYU Langone Health Perlmutter Cancer Center ### 1759644###Presenter###Assistant Professor of Medicine###NYU Langone Health Perlmutter Cancer Center###Presenter: – NYU Langone Health Perlmutter Cancer Center
###
4:20 PM – 5:05 PM ET
Session 16: BRAF Mutations: Identifying and Addressing a Rare Oncogenic Driver
4:20 PM – 5:05 PM ET
Session 16: BRAF Mutations: Identifying and Addressing a Rare Oncogenic DriverPresenter: – University of California, San Diego
Lyudmila Bazhenova, MD – University of California, San Diego ### 1612022###Presenter###Professor of Medicine###University of California, San Diego###Presenter: – University of California, San Diego
###
